EGFR and neoplasm: Pharmacological inhibition or genetic suppression of mPGES1 inhibits EGFR phosphorylation both in human epidermoid carcinoma cells and in in vivo animal models of cancer, with a consequent reduction in tumor growth and inhibition of angiogenesis [99].